Jim Cramer identifies eight companies eyeing the trillion-dollar club – Elon Musk’s Tesla and Eli Lilly are the top contenders – Apple (NASDAQ:AAPL), Amazon.com (NASDAQ:AMZN)

Jim Cramer has identified eight companies that could potentially reach a market capitalization of $1 trillion, alongside the technology giants Microsoft Corp. MSFT, Apple Inc. AAPLAnd Nvidia Corp. NVDAamong others.

What happened: Cramer called in his show “Mad Money” on Wednesday Eli Lilly and Co. LLY And Tesla Inc. TSL as the top contenders to join the elite group, CNBC reported.

So far, only the tech giants Microsoft, Apple, Nvidia, Alphabet Inc. GOOG GOOGLE, Amazon.com Inc. AmazonAnd Meta Platforms Inc. META have exceeded the market capitalization of $1 trillion.

“For me, Lilly is next,” Cramer said. “But the sheer popularity of Tesla could allow Musk to sneak back to the top and turn the Super Six back into the Magnificent Seven.”

For context: Under the leadership of Elon Musk Tesla had already exceeded the trillion dollar mark in market capitalization in 2021, becoming only the sixth US company to reach this milestone.

Cramer also identified Warren Buffet‘S Berkshire Hathaway Inc. BRK, BRK, Broadcom Inc. AVGO, JPMorgan Chase & Co. JPM, Walmart Inc. WMT, Visa Inc. VAnd ExxonMobil Corp. XOM as further contenders for the trillion dollar club.

Cramer emphasized the diversity and scope of Berkshire Hathaway’s portfolio, but noted that lower interest rates may be necessary for Berkshire Hathaway to achieve significant growth.

Eli Lilly’s rival Novo Nordisk NVO currently has a market capitalization of $635.67 billion.

See also: Elon Musk laughs at Jim Cramer saying he’d rather buy GM than Tesla, with electric giant’s stock up 44% since then: ‘Amazing’

Why it is important: Cramer’s prediction comes in the wake of the remarkable performance of Tesla stock, which, according to Cramer’s preference for General Motors about Tesla in late June. The price increase was attributed to Tesla’s second-quarter delivery figures, which exceeded estimates.

beginning of July Maurits Potthe CEO of Thematic ETFspredicted that the market for GLP-1 drugs to treat obesity could reach a size of one trillion US dollars or more, thereby disproving the prevailing notion of a duopoly between Eli Lilly and Novo Nordisk in the weight loss market.

Meanwhile, Cramer advised investors to consider buying Mag 7 shares when interest rates rise and to buy all stocks when interest rates fall, suggesting a possible change in market strategy.

A special note: Taiwan Semiconductor Manufacturing Co., Ltd. TSM The company’s market capitalization recently reached the $1 trillion mark and shares were trading significantly higher.

Continue reading:

Image via Shutterstock

Disclaimer: This content was created in part using AI tools and reviewed and published by Benzinga editors.